orbapin 5 20
TRANSCRIPT
![Page 1: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/1.jpg)
ORBAPIN 5/20 (Amlodipine BP 5 mg & Olmesartan INN 20 mg)
Presented by
Mohammed Moshiur Rahaman
Senior Brand Executive
Brand Management Department
Strategic Brand Management Division
The ACME Laboratories Ltd.
![Page 2: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/2.jpg)
ORBAPIN 5/20(Amlodipine 5 mg & Olmesartan 20 mg)
ORBA from ORBAS & PIN from AMLOPIN
![Page 3: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/3.jpg)
Price & Supply
Price: Orbapin 5/20 mg (08 taka)
Supply: 3x10 tablets
Product Group : A
![Page 4: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/4.jpg)
![Page 5: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/5.jpg)
![Page 6: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/6.jpg)
![Page 7: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/7.jpg)
Available Olmesartan & Combination (1Q, 2014)
Generic Introduce (Year)
Market (Crore)
Growth
Olmesartan
2010 18.5 50
Olmesrtan + HCTZ
2010 10.28 21
Olmesartan+
Amlodipine
2010 29.47 63
![Page 8: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/8.jpg)
Olmesartan & Amlodipine (2Q, 2014)
Generic Company Market (Crore)
Growth
Bizoran Beximco 17.14 42
Abecab ACI 5.05 108
Camlosart Square 3.56 999
Olmezest AM
Sun 2.34 70
![Page 9: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/9.jpg)
Indication
For the treatment of hypertension, alone or with other antihypertensive agents.
![Page 10: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/10.jpg)
Dosage & AdministrationOrbapin 5/20 mg Once daily OR may be increased after 2 weeks to a maximum dose of two tablets
Recommended for patients with moderate to marked renal impairment (Creatinine clearance < 40 mL/min)
![Page 11: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/11.jpg)
Not recommended
In patient's ≥ 75 years old OrWith hepatic impairment OrBelow Creatinine Clearance <20 mL/min
![Page 12: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/12.jpg)
Target doctorsCardiologistEndocrinologistNeurologistMedicine specialistNephrologist
![Page 13: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/13.jpg)
![Page 14: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/14.jpg)
![Page 15: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/15.jpg)
![Page 16: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/16.jpg)
![Page 17: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/17.jpg)
![Page 18: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/18.jpg)
![Page 19: Orbapin 5 20](https://reader034.vdocuments.us/reader034/viewer/2022050722/55b172ecbb61ebd4698b477c/html5/thumbnails/19.jpg)